Hyderabad-based Aurobindo Pharma has informed that it has secured approval from US Food and Drug Administration (USFDA) for marketing Cyclobenzaprine hydrochloride tablets.

Under the approval, the company will market and distribute the drug in 10 mg and 5 mg strengths. The drug is a muscle relaxant, which is prescribed to relieve muscle spasms resulting from injuries such as sprains, strains, or pulls.

Recently, the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Didanosine Delayed Release
(Enteric-Coated) Capsules 125mg, 200mg, 250mg and 400mg.